Pancreatic Cancer Research

Clinical trialPhase 1Terminated

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients With Advanced Pancreatic Cancer

NCT03825289↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Stopped earlyLack of Funding (Business decision)
Phase
Phase 1
Status
Terminated
Study type
Interventional
Start
30 January 2019
Expected end
3 August 2025
Enrollment
25 participants
Sites
2
Primary outcomes
Rate of dose-limiting toxicities during the DLT assessment window.
Sponsor
Other
Results posted
No
Last update
14 May 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 10